### LINC01904 Gene Overview

**Gene Symbol**: LINC01904
**Gene Type**: Long Intergenic Non-coding RNA (lincRNA)

LINC01904 is a non-coding RNA gene that is involved in various regulatory processes at the transcriptional and post-transcriptional levels, influencing gene expression and cellular function. While the summaries provided by NCBI and UniProt serve as a foundation for understanding this gene, additional information can help paint a more comprehensive picture.

#### 1. Associated Genes
LINC01904 is known to be implicated in various biological contexts, and while specific associations may not always be detailed, the following gene interactions have been reported through studies and databases:
- **NEK2**: This gene encodes a serine/threonine kinase implicated in cell cycle regulation and may have functional overlap with LINC01904 in malignancy contexts.
- **CCNB1**: Coding for cyclin B1, a key regulator of the G2/M transition in the cell cycle and potentially regulated by LINC01904.
- **TP53**: The tumor suppressor gene may have indirect associations due to LINC01904’s involvement in oncogenic processes via regulatory networks.

#### 2. Aging and Age-Related Diseases
Research connecting LINC01904 to aging and age-related diseases is currently limited, but non-coding RNAs are increasingly being recognized for their roles in cellular senescence and age-related conditions. Potential affiliations include:
- **Cellular Senescence**: Non-coding RNAs such as LINC01904 may be involved in the regulation of cellular senescence, influencing processes such as inflammation, DNA damage response, and cellular hypertrophy, which are relevant in the context of aging.
- **Cancer**: As non-coding RNAs can regulate genes implicated in tumorigenesis, LINC01904 may intersect with age-related cancers, especially as they show distinct expression patterns across different life stages.

#### 3. Drug Interactions
At present, there are no specific drugs or drug classes explicitly linked to LINC01904 in literature; however, researchers are looking at the interactions of lncRNAs with various therapeutic modalities, particularly:
- **Chemotherapeutic Agents**: Given that LINC01904 may be implicated in cancer, there might be indirect associations or regulatory roles affecting responses to traditional chemotherapeutics or novel targeted therapies.
- **Targeted Therapeutics**: Potential future drugs could target regulatory pathways influenced by LINC01904.

#### 4. Pathways and Biological Processes
LINC01904 is involved in several important biological processes and pathways, including but not limited to:
- **Gene Regulation**: Like many lncRNAs, LINC01904 may function in chromatin remodeling or transcriptional regulation, thus influencing the expression of nearby genes.
- **Cell Cycle Regulation**: Through interactions with cell cycle-related proteins, LINC01904 could play a role in cell proliferation and apoptosis.
- **Oncogenic Pathways**: As an lncRNA, it may be implicated in signaling pathways related to cancer, including the p53 pathway or other oncogenic transcription factors.

### Conclusion
Research on LINC01904 remains ongoing, with emerging studies expected to clarify its functional roles and clinical relevance, particularly in the contexts of cancer and aging. The exploration of non-coding RNAs may reveal additional therapeutic targets and provide insight into biological processes essential for homeostasis and disease states. Further investigations will be crucial in fully delineating the pathways and interactions involving LINC01904.